14 November 2022
Latham & Watkins Advises on Rallybio’s US$50 Million Public Offering
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Alison Haggerty Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Danny Shulman | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Stacy Hwang | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Akina Newbraugh | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Yulong Li | Latham & Watkins LLP | Associate | capital markets | Not stated |
Stated terms
- Stated value
- USD 50m (US$50 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Rallybio Corporation (Issuer)